Amgen Inc., AMGN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Amgen Inc., AMGN has a market cap of 108612.32. Since its IPO date on the 9/7/1984, Amgen Inc., AMGN performance year to date is -7.69%. Today Amgen Inc., AMGN has gained -0.32%, with a current price of 145.53.
Ownership of the company is 0.13% for insider ownership while institutional ownership is 79.90%. The management of the company have seen the company have a payout ratio of 37.50%. Return of assets are at 10.10%, with return on investment at 12.50%.
In terms of debt levels and profit levels, Amgen Inc., AMGN is seeing a long-term debt/equity of 0.99. While Total debt/equity is 1.15. With a profit margin of 33.60%, this is combined with a gross margin of 81.50%, and operating margin of 41.40%. Amgen Inc. ability to meet debt levels, with a current ratio of 4.3, while the quick ratio is 4.1.
For the last year Amgen Inc., AMGN has seen a EPS growth of 35.20%. A performance for the year of -6.98%. The 52-week high is -17.15%, and the 52-week low is 9.63%. The average volume for Amgen Inc., AMGN is 781176.
With a target price of 182.21, can Amgen Inc., AMGN reach this target? Looking at the value indicators of Amgen Inc., AMGN. Amgen Inc. has a P/E of 14.58 and a forward P/E of 11.65. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.94. Amgen Inc. also has a P/S and a P/B of 4.81 and 3.54 respectively. For P/cash, Amgen Inc. has a value of 2.86, while it is 385.15 for P/free cash flow.
At the current price of 145.53, Amgen Inc. has a dividend yield of 2.74%. We see a return on equity of 25.80%.
Looking more long-term Amgen Inc., is projected to get an EPS growth for the next five years of 7.52%. In the short-term an EPS growth of 8.37% in the next year is forecasted. This is after a EPS growth of 35.20% for this year and for the last five years a 13.60% growth has been seen.